Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR(+)/HER2(-) Breast Cancer
neoMONARCH II期新辅助治疗研究显示，阿贝西利联合阿那曲唑可有效抑制细胞周期并上调免疫反应，该研究针对HR(+)/HER2(-)乳腺癌患者。
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-19-1425
Hurvitz, Sara A; Martin, Miguel; Press, Michael F; Chan, David; Fernandez-Abad, María; Petru, Edgar; Rostorfer, Regan; Guarneri, Valentina; Huang, Chiun-Sheng; Barriga, Susana; Wijayawardana, Sameera; Brahmachary, Manisha; Ebert, Philip J; Hossain, Anwar; Liu, Jiangang; Abel, Adam; Aggarwal, Amit; Jansen, Valerie M; Slamon, Dennis J
肿瘤
HER2
肿瘤免疫
ARC
乳腺癌
细胞生物学
免疫/内分泌
